Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue - Concepedia

Concepedia

Publication | Open Access

Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue

DOI Full Paper Access

90

Citations

21

References

2016

Year

Marisa Dolled‐Filhart, Darren Locke, Tiffany Murphy, Frank Lynch, Jennifer H. Yearley, Dennis M. Frisman, Robert J. Pierce, Russell Weiner, Dianna Wu, Kenneth Emancipator

Archives of Pathology & Laboratory Medicine

Abstract

- The immunohistochemistry assay using the anti-PD-L1 antibody 22C3 merits further investigation in clinical trials and prevalence assessments to further understand the prognostic and predictive value of PD-L1 expression in cancer.

References

	Year	Citations

Page 1